期刊文献+

应用流式细胞术研究多发性骨髓瘤相关预后因素

原文传递
导出
摘要 应用流式细胞术对多发性骨髓瘤患者外周血中内皮祖细胞、循环内皮细胞、循环骨髓瘤浆细胞以及骨髓中恶性浆细胞相关的多项指标(抗凋亡因子MCL-1、CD45、CD56、CD138)等进行检测,并评估其对多发性骨髓瘤诊断、疗效判断和预后的影响。
出处 《国际输血及血液学杂志》 CAS 2006年第6期521-524,共4页 International Journal of Blood Transfusion and Hematology
基金 江苏省135工程医学重点人才基金项目(RC2004044)
  • 相关文献

参考文献25

  • 1Ladettol M, Valletl S, Trojan A, et al. Cyclooxygenase-2 (cox-2) is frequently expressed in multiple myeloma and is an independent predictor of poor outcome. Blood, 2005, 105(12): 4784-4791.
  • 2Hideshima T, Bergsagel PL, Kuehl WM, et al. Advances in biology of multiple myeloma: clinical applications. Blood, 2004,104(3): 607-618.
  • 3Barlogie B, Shaughnessy J, Tricot G, et al. Treatment of multiple myeloma. Blood, 2004, 103(1): 20-32.
  • 4Vacca A, Ria R, Semeraro F, et al. Endothelial cells in the bone marrow of patients with multiple myeloma. Blood, 2003, 102(9):3340-3348.
  • 5Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med, 2003, 9(6): 702-712.
  • 6Zhang H, Vakil V, Braunstein M, et al. Circulating endothelial progenitor cells in multiple myeloma : implications and significance.Blood, 2005, 105(8): 3286-3294.
  • 7Rigolin GM, Fraulini C, Ciccone M, et al. Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion. Blood,2006, 107(6): 2531-2535.
  • 8Nowakowski GS, Witzig TE, Dingli D, et al. Circulating plasma cells detected by flow cytometry as a predictor of survival in 302 patients with newly diagnosed multiple myeloma. Blood, 2005, 106(7) : 2276-2279.
  • 9Dingli D, Nowakowski GS, Dispenzieri A, et al. Flow cytometric detection of circulating myeloma cells pretransplant in patients with multiple myeloma: a simple risk stratification system. Blood,2006, 107(8): 3384-3388.
  • 10Greipp PR, Kumar S. Plasma cell labeling index. Methods Mol Med, 2005, 113: 25-35.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部